Clinical effectiveness, safety and immunogenicity of anti-TNF therapy in Crohn's disease: 12-month data from the PANTS study

被引：0
|
作者：
Kennedy, N. A. [1 ]
Heap, G. [1 ,2 ]
Hamilton, B. [1 ]
Walker, G. J. [1 ]
Bewshea, C. [1 ]
Bouri, S. [3 ]
Goodhand, J. [1 ]
Ahmad, T. [1 ]
机构：
[1] Univ Exeter, IBD Pharmacogenet, Exeter, Devon, England
[2] Abbvie, Chicago, IL USA
[3] St Marks Hosp, IBD Unit, London, England
来源：
JOURNAL OF CROHNS & COLITIS | 2018年 / 12卷
关键词：
D O I：
暂无
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
OP031
引用
收藏
页码：S21 / S22
页数：2
相关论文
共 50 条
  • [1] CLINICAL EFFECTIVENESS, SAFETY AND IMMUNOGENICITY OF ANTI-TNF THERAPY IN CROHN'S DISEASE: 12-MONTH DATA FROM PANTS
    Kennedy, Nicholas
    Heap, Graham
    Walker, Gareth
    Bewshea, Claire
    Bouri, Sonia
    Goodhand, James
    Ahmad, Tariq
    GUT, 2018, 67 : A59 - A59
  • [2] CLINICAL EFFECTIVENESS, SAFETY AND IMMUNOGENICITY OF ANTI-TNF THERAPY IN CROHN'S DISEASE: 12 MONTH DATA FROM THE PANTS STUDY
    Kennedy, Nicholas A.
    Heap, Graham A.
    Hamilton, Benjamin
    Walker, Gareth J.
    Bewshea, Claire M.
    Bouri, Sonia
    Goodhand, James
    Ahmad, Tariq
    GASTROENTEROLOGY, 2018, 154 (06) : S44 - S44
  • [3] Anti-TNF therapy and Crohn's disease
    Peyrin-Biroulet, L.
    GASTROENTEROLOGIE CLINIQUE ET BIOLOGIQUE, 2008, 32 (05): : 478 - 481
  • [4] Anti-TNF Therapy in Crohn's Disease
    Adegbola, Samuel O.
    Sahnan, Kapil
    Warusavitarne, Janindra
    Hart, Ailsa
    Tozer, Philip
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2018, 19 (08)
  • [5] Anti-TNF therapy for Crohn's disease
    D'Haens, G
    CURRENT PHARMACEUTICAL DESIGN, 2003, 9 (04) : 289 - 294
  • [6] PROSPECTIVE ANTI-TNF WITHDRAWAL IN QUIESCENT CROHN'S DISEASE-12 MONTH CLINICAL OUTCOMES
    Squires, S.
    Boal, A.
    Hamid, R.
    Heydtmann, M.
    Naismith, G.
    GUT, 2015, 64 : A437 - A437
  • [7] PANTS extension study: how best to use anti-TNF drugs in Crohn's disease
    Parkes, Gareth C.
    Hedin, Charlotte R. H.
    LANCET GASTROENTEROLOGY & HEPATOLOGY, 2024, 9 (06): : 489 - 491
  • [8] Comparative Effectiveness of Anti-TNF Therapy and Vedolizumab in Crohn's Disease Patients
    Chen, Nai-Yu
    Chiu, Yung-Ting
    Chuang, Chiao-Hsiung
    Chang, Yu-Ching
    Cheng, Ching-Lan
    PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2024, 33 : 356 - 356
  • [9] Comparative Safety and Effectiveness of Ustekinumab and Anti-TNF in Elderly Crohn's Disease Patients
    Gebeyehu, Gerum Gashaw
    Broglio, Giacomo
    Liu, Eleanor
    Limdi, Jimmy K.
    Selinger, Christian
    Fiske, Joseph
    Razanskaite, Violeta
    Smith, Philip J.
    Flanagan, Paul K.
    Subramanian, Sreedhar
    INFLAMMATORY BOWEL DISEASES, 2024,
  • [10] Safety considerations when using anti-TNFα therapy to treat Crohn's disease
    Pagnini, Cristiano
    Arseneau, Kristen O.
    Cominelli, Fabio
    EXPERT OPINION ON DRUG SAFETY, 2015, 14 (01) : 31 - 44
12345